In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against coryneform bacteria

被引:17
作者
Martínez-Martínez, L
Pascual, A
Suárez, AI
Perea, EJ
机构
[1] Univ Seville, Sch Med, Dept Microbiol, Seville 41080, Spain
[2] Hosp Univ Virgen Macarena, Dept Microbiol, Seville, Spain
关键词
D O I
10.1128/AAC.42.12.3290
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activity of ketolide HMR 3647 against coryneform bacteria isolated from clinical samples was evaluated. Except against Corynebacterium jeikeium and C. urealyticum, HMR 3647 showed high activity against Corynebacterium spp., being more active than 14- and 16-membered macrolides, azithromycin, or clindamycin. HMR 3647 also had high in vitro activity against Brevibacterium spp. and Listeria monocytogenes.
引用
收藏
页码:3290 / 3292
页数:3
相关论文
共 15 条
[1]  
Bryskier A, 1997, INFEC DIS T, V21, P39
[2]  
COLLINS MD, 1988, FEMS MICROBIOL LETT, V49, P349
[3]   Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum [J].
Funke, G ;
Lawson, PA ;
Bernard, KA ;
Collins, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (05) :1124-1128
[4]   Antimicrobial susceptibility patterns of some recently established coryneform bacteria [J].
Funke, G ;
Punter, V ;
vonGraevenitz, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2874-2878
[5]   Clinical microbiology of coryneform bacteria [J].
Funke, G ;
vonGraevenitz, A ;
Clarridge, JE ;
Bernard, KA .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (01) :125-+
[6]   INVITRO ACTIVITY OF 79 ANTIMICROBIAL AGENTS AGAINST CORYNEBACTERIUM GROUP-D2 [J].
GARCIARODRIGUEZ, JA ;
SANCHEZ, JEG ;
BELLIDO, JLM ;
MAYORAL, TN ;
SANCHEZ, EG ;
GARCIA, IG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) :2140-2143
[7]   Antimicrobial activity of RU-66647, a new ketolide [J].
Jones, RN ;
Biedenbach, DJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 27 (1-2) :7-12
[8]  
Martinez-Martinez L, 1998, REV MED MICROBIOL, V9, P55
[9]   Antimicrobial susceptibility pattern of Corynebacterium striatum [J].
MartinezMartinez, L ;
Pascual, A ;
Bernard, K ;
Suarez, AI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2671-2672
[10]  
National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS